Skip to main content
Premium Trial:

Request an Annual Quote

Genedata Integrates its Analyst Software with TranSMART Platform


NEW YORK (GenomeWeb) – Genedata said this week that it has integrated its Genedata Analyst software with the TranSMART platform, an open-source knowledge-management platform managed by the TranSMART Foundation that lets users integrate phenotype data and molecular information in translational research and personalized medicine projects.

The combined product provides a single platform for analyzing and sharing omics and clinical data that reduces the amount of time required to import, export, integrate, and format data for processing; removes error-prone manual steps; and more, the company said. Genedata will showcase the solution at the Bio-IT World Conference next week in Boston.

The TranSMART platform is also integrated with the GenoSpace system, which offers cloud power and software to help researchers and clinicians analyze, share, and store both clinical and genomic information; and with the BT for Life Sciences cloud infrastructure, a service that telecommunications company BT launched last year to support scientists from pharmaceutical, biotechnology, devices, and diagnostics companies, as well as those in academia and government

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.